CompletedNCT03807882
Official study titleComparison of Maintenance ECT Versus Clozapine on Psychopathology and Cerebral Hemodynamics in Treatment-resistant Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In BhubaneswarSchizophreniaMedication studyAges 18–60
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
CompletedNCT00802100
Official study titleComparison of Optimal Antipsychotic Treatments for Schizophrenia Pilot Study
This study has finished and is no longer accepting participants.
Multiple locations, including ColtonSchizophreniaMedication studyAges 18–40
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT00589914
What is this study about?Researchers compared Paliperidone palmitate and RISPERDAL CONSTA to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamSchizophreniaMedication studyAges 18+
- Countries
- United States, France, Austria, + 11 others
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT04040998
Official study titleCompensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia
This study has finished and is no longer accepting participants.
In TaoyuanSchizophreniaBehavioural studyAges 20–65
- Countries
- Taiwan
- Sponsor
- Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
CompletedNCT01055509
Official study titleEffectiveness of Cognitive Adaptation Training Applied to Cognitive Impairment in Schizophrenia - A Randomised Trial
This study has finished and is no longer accepting participants.
Multiple locations, including AabenraaSchizophreniaBehavioural studyAges 18–70
- Countries
- Denmark
- Sponsor
- University of Southern Denmark